• Home
  • About
  • News
  • Contact
  • Rinn Network ↗

FUNDED BY

Innovative Mechanochemical Processes to synthesise green ACTIVE pharmaceutical ingredients

by tr0han | Oct 12, 2023 | Health, Impact, Small Molecule, Sustainability

IMPACTIVE: Innovative Mechanochemical Processes to synthesise green ACTIVE pharmaceutical ingredients. Prof. Lidia Tajber, Trinity College Dublin and SSPC investigator is deputy coordinator on the €8M consortium project. The project aims to address the issue of...

Long Acting Medicines for Complex Therapeutics Needed Now

by tr0han | Oct 9, 2023 | Biologics, Health, Impact, Small Molecule

LongActNow is a Marie Skłodowska-Curie Action (MSCA) led by a consortium of international academic and industrial centres at: University of Limerick (UL), SSPC, Trinity College Dublin (TCD), TU Dortmund University (TUD) & The Janssen Pharmaceutical Companies of...

US-Ireland Centre-to-Centre nanoparticle partnership

by tr0han | Sep 12, 2023 | Health, Impact, Small Molecule, Sustainability

The US-Ireland Centre-to-Centre Partnership: Partnership in Continuous Manufacturing for Nano-based Drug Products (C2C) Project 1 leads: Luis Padrela, Kevin Ryan, University of Limerick, Rohit Ramachanddran, Rutgers Project 2 leads: Kieran Hodnett, Sarah Hudson,...
EPSRC-SFI Centre for Doctoral Training (CDT) in Transformative Pharmaceutical Technologies

EPSRC-SFI Centre for Doctoral Training (CDT) in Transformative Pharmaceutical Technologies

by tr0han | Sep 12, 2023 | Biologics, Health, Impact, Small Molecule, Sustainability

EPSRC-SFI Centre for Doctoral Training (CDT) in Transformative Pharmaceutical Technologies. The CDT is funded through a partnership between the Engineering and Physical Sciences Research Council (EPSRC) in the UK, and Science Foundation Ireland. Website:...

Nature-ETN Nucleic Acids for Future Gene Editing, Immunotherapy and Epigenetic Sequence Modification

by tr0han | Sep 7, 2023 | Health, Impact, Small Molecule

Nature–ETN: Nucleic Acids for Future Gene Editing, Immunotherapy and Epigenetic Sequence Modification Website: https://www.nature-etn.eu/ Budget: €4.04M Challenge: Nucleic acid (NA) therapeutics are expected to yield major advances in the treatment of human diseases,...

Improving the efficiency of biotherapeutic production

by tr0han | Sep 5, 2023 | Biologics, Health, Impact

Proteomic and Post-translational modification characterisation of recombinant Chinese hamster ovary (CHO) cells to improve the efficiency of biotherapeutic production Paula Meleady’s research is based on the ‘Proteomic and Post-translational modification...
« Older Entries
Next Entries »

Recent Posts

  • Rinn Pharma & Biopharma PhD opportunities – Positions available 07.10.2026
  • Sarah Hayes Named Biopharma & Lifesciences Connected Person of the Month for June 2026
  • Rinn Pharma & Biopharma Expands European Research Collaboration Through NordicPharmaTrain Partnership
  • Rinn Pharma & Biopharma and ArrayPatch Collaborate to Advance Novel Intradermal Therapy
  • Jordan Loughlin SSPC industry placement at Clarochem

Recent Comments

No comments to show.

Research & Innovation in Making Medicines. Part of the Rinn Network — Radical Collaboration.

CONTACT

Rinn Pharma & Biopharma
Bernal Institute,
University of Limerick,
Ireland

Tel: +353 61 233754

FOLLOW

  • Follow
  • Follow
  • Follow

FUNDED BY

© 2026 Rinn Pharma & Biopharma

Privacy PolicyCookie Policy

Disclaimer

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}